Colorectal cancer and genetic alterations in the Wnt pathway
- PMID: 17143297
- DOI: 10.1038/sj.onc.1210059
Colorectal cancer and genetic alterations in the Wnt pathway
Abstract
In colorectal tumours, Wnt pathway genetics continues to be dominated by mutations in the adenomatous polyposis coli (APC) gene. Germline mutations cause familial adenomatous polyposis and at least two-thirds of sporadic colorectal tumours also acquire APC mutations, quite possibly as the initiating events in tumorigenesis. These mutations almost always cause loss of the C-terminal functions of the APC protein - probably involved in microtubule binding, cell polarity and chromosome segregation - and deletion of the SAMP repeats that are important for binding to axin and formation of the beta-catenin phosphorylation complex. The truncated APC proteins are, in general, stable and almost certainly retain some activity in beta-catenin binding. The 'two hits' at APC are coselected so as to produce an optimal activation of Wnt signalling (just-right hypothesis). In a minority of colorectal tumours, Wnt activation can occur through mutations that affect phosphorylation sites within exon 3 of beta-catenin, causing protein stabilization. In other tumours, epigenetic transcriptional silencing or mutation of the secreted frizzled-related proteins may modulate Wnt levels. Mutations in the Wnt components AXIN1, AXIN2 and TCF4 have been found in microsatellite-unstable colon cancers, but it is not clear in every case whether these changes are functional. Therapeutic modulation of the Wnt pathway remains an attractive therapeutic possibility for colorectal carcinomas.
Similar articles
-
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1.Nat Genet. 2000 Mar;24(3):245-50. doi: 10.1038/73448. Nat Genet. 2000. PMID: 10700176
-
Refining the relation between 'first hits' and 'second hits' at the APC locus: the 'loose fit' model and evidence for differences in somatic mutation spectra among patients.Oncogene. 2003 Jul 3;22(27):4257-65. doi: 10.1038/sj.onc.1206471. Oncogene. 2003. PMID: 12833148
-
[Familial adenomatous polyposis syndrome (FAP): pathogenesis and molecular mechanisms].Med Klin (Munich). 2003 Dec 15;98(12):776-82. doi: 10.1007/s00063-003-1325-2. Med Klin (Munich). 2003. PMID: 14685680 Review. German.
-
Beta-catenin degradation mediated by the CID domain of APC provides a model for the selection of APC mutations in colorectal, desmoid and duodenal tumours.Hum Mol Genet. 2009 Jan 15;18(2):213-26. doi: 10.1093/hmg/ddn338. Epub 2008 Oct 14. Hum Mol Genet. 2009. PMID: 18854359
-
Vitamin D and Wnt/beta-catenin pathway in colon cancer: role and regulation of DICKKOPF genes.Anticancer Res. 2008 Sep-Oct;28(5A):2613-23. Anticancer Res. 2008. PMID: 19035286 Review.
Cited by
-
Transcriptome analysis of potential candidate genes and molecular pathways in colitis-associated colorectal cancer of Mkp-1-deficient mice.BMC Cancer. 2021 May 25;21(1):607. doi: 10.1186/s12885-021-08200-0. BMC Cancer. 2021. PMID: 34034704 Free PMC article.
-
Transposon mutagenesis identifies candidate genes that cooperate with loss of transforming growth factor-beta signaling in mouse intestinal neoplasms.Int J Cancer. 2017 Feb 15;140(4):853-863. doi: 10.1002/ijc.30491. Epub 2016 Nov 7. Int J Cancer. 2017. PMID: 27790711 Free PMC article.
-
Arsenic and chromium in drinking water promote tumorigenesis in a mouse colitis-associated colorectal cancer model and the potential mechanism is ROS-mediated Wnt/β-catenin signaling pathway.Toxicol Appl Pharmacol. 2012 Jul 1;262(1):11-21. doi: 10.1016/j.taap.2012.04.014. Epub 2012 Apr 19. Toxicol Appl Pharmacol. 2012. PMID: 22552367 Free PMC article.
-
Novel read through agent: ZKN-0013 demonstrates efficacy in APCmin model of familial adenomatous polyposis.J Mol Med (Berl). 2023 Apr;101(4):375-385. doi: 10.1007/s00109-023-02291-x. Epub 2023 Feb 20. J Mol Med (Berl). 2023. PMID: 36808265
-
Sonic Hedgehog Protein is Frequently Up-Regulated in Pancreatic Cancer Compared to Colorectal Cancer.Pathol Oncol Res. 2020 Jan;26(1):551-557. doi: 10.1007/s12253-018-00564-2. Epub 2018 Dec 11. Pathol Oncol Res. 2020. PMID: 30539521
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials